BMJ:开始使用别嘌呤醇时,预防痛风发作的治疗副作用有多常见?
本文由小咖机器人翻译整理
期刊来源:BMJ
原文链接:https://doi.org/10.1136/bmj.q514
摘要内容如下:
研究:Roddy E,Bajpai R,Forrester H等。开始降尿酸治疗痛风时秋水仙碱和非甾体抗炎药预防的安全性:英国临床实践研究数据链中的倾向评分匹配队列研究Ann Rheum DIS 2023;82:1618-25.要阅读完整的NIHR警报,请访问:https://evidence.nihr.ac.uk/alert/how-common-are-side-effects-of-treatment-to-prevent-gout-flares-when-starting-allopurinol/.
英文原文如下:
Abstracts
The studyRoddy E, Bajpai R, Forrester H, et al. Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. Ann Rheum Dis 2023;82:1618-25.To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/how-common-are-side-effects-of-treatment-to-prevent-gout-flares-when-starting-allopurinol/.
-----------分割线---------
点击链接:https://www.mediecogroup.com/community/user/vip/categories/ ,成为医咖会员,获取12项专属权益。

确认删除